Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Medicina Clínicaarrow_drop_down
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
Medicina Clínica
Article . 2012 . Peer-reviewed
License: Elsevier TDM
Data sources: Crossref
versions View all 1 versions
addClaim

Vía Wnt y esclerostina como nuevas dianas para la evaluación y el tratamiento de la osteoporosis

Authors: Guillermo Alonso; Antonia García-Martín; Manuel Muñoz-Torres;

Vía Wnt y esclerostina como nuevas dianas para la evaluación y el tratamiento de la osteoporosis

Abstract

Resumen El creciente conocimiento de la biologia osea ha permitido la identificacion de nuevas vias intracelulares que participan en la regulacion del remodelado y de la actividad de los osteoblastos. En este aspecto, la caracterizacion de la via Wnt ha supuesto un gran avance por su implicacion y relevancia en alteraciones del metabolismo mineral. El mejor conocimiento de estas vias de senalizacion puede permitir desarrollar nuevos marcadores diagnosticos, asi como nuevos farmacos para las enfermedades metabolicas oseas, donde a pesar del amplio arsenal terapeutico disponible aun persisten necesidades no cubiertas. En la presente revision realizamos una aproximacion al descubrimiento y funciones de la via Wnt con especial atencion a sus efectos oseos. A continuacion, revisamos brevemente los datos principales acerca de su antagonista endogeno, la esclerostina, por ser donde la investigacion farmacologica esta mas avanzada.

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    1
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
1
Average
Average
Average
Upload OA version
Are you the author of this publication? Upload your Open Access version to Zenodo!
It’s fast and easy, just two clicks!